Serovia is a specialty injectable platform committed to delivering better healthcare outcomes through a focused portfolio and by partnering with leading firms for new technologies. As part of the Tenshi Group, Serovia brings together value-add expertise, a strong governance backbone, and deep understanding of global healthcare needs. We are building a state-of-the-art injectable manufacturing facility in the United States, reflecting our commitment to quality, compliance, and sustainable growth. Backed by the same investors who support OneSource, Strides and other successful ventures, Serovia concentrates on complex, differentiated, and first-to-market opportunities, including select 505(b)(2) NDA programs. Our goal is to build trusted partnerships and create lasting value for hospitals, caregivers, and patients through innovation, disciplined execution, and market insight. At the heart of Serovia’s journey is our human capital vision, shared across the Tenshi Group: to attract, develop, and empower diverse talent through continuous learning, cross-entity collaboration, and a culture that blends science with purpose. We welcome collaboration with commercial partners, customers, and professionals who share our ambition to shape the future of specialty injectables. For collaborations and professional engagement, please contact: • Chris Eckerle, Site Leader, Branchburg Site, United States | chris.eckerle@serovia.com • Kalpesh Vohra, Head - Group HR CoE, HQ, India | kalpesh.vohra@serovia.com
| Employees | 24 (16 on RocketReach) |
| Founded | 2025 |
| Industry | Pharmaceutical Manufacturing |
Looking for a particular Serovia employee's phone or email?
Dhriti Sethi is the CEO of Serovia.
16 people are employed at Serovia.